Effectiveness of Dry Needling Adjuvant to Selective Serotonin Reputake Inhibitors Versus Trigger Point Injection for Pain Management in Fibromyalgia
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- Pittsburgh Sleep Quality Index (PSQI)
研究概览
简要总结
The principal objective is to contribute valuable insights that hold direct implications for medical practice and patient care, with the potential to influence health policy pertaining to fibromyalgia management.
详细描述
The study aims to outline distinct patient subgroups manifesting heightened responsiveness to one therapeutic intervention vis-à-vis the other, thereby facilitating the formulation of more personalized and efficacious treatment modalities.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Stable on SSRIs for at least three months (for Group A)
- •Age between 18 and 65 years
- •Participants suffering from recent cervical pain without any pathology
排除标准
- •Presence of any other chronic pain conditions.
- •Contraindications to SSRIs or trigger point injections.
- •Pregnancy or lactation.
- •History of psychiatric disorders other than depression and anxiety
研究组 & 干预措施
Dry Needling
干预措施: Dry Needling (Other)
Dry Needling
干预措施: serotonin reuptake inhibitor (SSRI) (Drug)
Trigger points injections
干预措施: Trigger points injections (Procedure)
结局指标
主要结局
Pittsburgh Sleep Quality Index (PSQI)
时间窗: 12 Months
It includes 19 items that generate seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The total score ranges from 0 to 21, with higher scores indicating poorer sleep quality.
Fibromyalgia Impact Questionnaire:
时间窗: 12 months
It includes questions related to physical functioning, work status, depression, anxiety, sleep, pain, stiffness, fatigue, and well-being. Scores on the FIQ range from 0 to 100, with higher scores indicating greater impact and symptom severity
次要结局
未报告次要终点
研究者
Muhammad Naveed Babur
Principal Investigator
Superior University